Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cresco Labs (CRLBF) Non Operating Income (2020 - 2026)

Cresco Labs filings provide 7 years of Non Operating Income readings, the most recent being -$14.0 million for Q1 2026.

  • On a quarterly basis, Non Operating Income rose 3.72% to -$14.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$66.9 million, a 43.88% increase, with the full-year FY2025 number at -$11.2 million, up 90.54% from a year prior.
  • Non Operating Income hit -$14.0 million in Q1 2026 for Cresco Labs, down from -$11.6 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of -$757000.0 in Q3 2022 to a low of -$73.3 million in Q2 2024.
  • Median Non Operating Income over the past 5 years was -$14.3 million (2023), compared with a mean of -$17.7 million.
  • Biggest five-year swings in Non Operating Income: surged 93.61% in 2022 and later crashed 1410.57% in 2023.
  • Cresco Labs' Non Operating Income stood at -$13.4 million in 2022, then fell by 6.71% to -$14.3 million in 2023, then decreased by 14.49% to -$16.4 million in 2024, then increased by 29.06% to -$11.6 million in 2025, then decreased by 20.41% to -$14.0 million in 2026.
  • The last three reported values for Non Operating Income were -$14.0 million (Q1 2026), -$11.6 million (Q4 2025), and -$27.9 million (Q3 2025) per Business Quant data.